Transcription of PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
{{id}} {{{paragraph}}}
Example: bankruptcy
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. COVIFENZ . COVID-19 Vaccine (plant-based virus-like particles [VLP], recombinant, adjuvanted). Emulsion for Intramuscular Injection Multiple Dose Vial (Each vial contains 10 doses of mL after mixing with AS03 adjuvant). Active Immunizing Agent ATC Code: J07BX03. Date of Initial Authorization: February 24, 2022. Medicago Inc. 1020 route de l' glise, bureau 600. Qu bec, QC G1V 3V9. Canada Submission Control Number: 254598. 2022. Medicago Inc. All Rights Reserved. COVIFENZ and Medicago are registered trademarks of Medicago Inc. COVIFENZ (COVID-19 Vaccine, plant-based [VLP], recombinant, adjuvanted) PRODUCT MONOGRAPH Page 1 of 25.
Feb 24, 2022 · For a complete listing, see : 6 : DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. ... (COVID-19 Vaccine, plant-based [VLP], recombinant, adjuvanted) Product Monograph Page 8 of 25 To help ensure the traceability of vaccines for patient immunization record-keeping as well as
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: